Franklin Resources Inc. Raises Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Franklin Resources Inc. raised its position in IQVIA Holdings Inc. (NYSE:IQV) by 1.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 501,807 shares of the medical research company’s stock after buying an additional 6,011 shares during the quarter. Franklin Resources Inc. owned approximately 0.28% of IQVIA worth $117,031,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Capital Performance Advisors LLP purchased a new stake in IQVIA in the third quarter valued at approximately $27,000. Park Place Capital Corp purchased a new stake in IQVIA in the third quarter valued at approximately $28,000. Itau Unibanco Holding S.A. purchased a new stake in IQVIA in the second quarter valued at approximately $29,000. International Assets Investment Management LLC acquired a new position in shares of IQVIA in the second quarter valued at approximately $32,000. Finally, Avior Wealth Management LLC increased its holdings in shares of IQVIA by 117.6% in the third quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company’s stock valued at $38,000 after purchasing an additional 87 shares during the period. Hedge funds and other institutional investors own 89.62% of the company’s stock.

IQVIA Stock Down 0.7 %

IQVIA stock opened at $199.06 on Monday. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The firm has a market capitalization of $36.13 billion, a price-to-earnings ratio of 26.12, a price-to-earnings-growth ratio of 2.05 and a beta of 1.49. IQVIA Holdings Inc. has a fifty-two week low of $187.62 and a fifty-two week high of $261.73. The stock’s fifty day moving average is $212.24 and its two-hundred day moving average is $224.20.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on IQV shares. Bank of America dropped their target price on IQVIA from $255.00 to $235.00 and set a “buy” rating on the stock in a report on Friday. Morgan Stanley dropped their target price on IQVIA from $280.00 to $265.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Robert W. Baird dropped their target price on IQVIA from $213.00 to $212.00 and set a “neutral” rating on the stock in a report on Wednesday, December 11th. TD Cowen dropped their target price on IQVIA from $270.00 to $255.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Finally, Redburn Atlantic started coverage on IQVIA in a report on Monday, October 14th. They set a “buy” rating and a $276.00 price objective on the stock. Four research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $256.19.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.